Gilead Sciences, Inc.
HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES
Last updated:
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
3 Dec 2020
Issue date:
27 May 2021